Investors with a lot of money to spend have taken a bearish stance on GSK (NYSE:GSK). And retail traders should know. We noticed this today when the positions showed up on publicly available options ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the May 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK plc has disclosed that David Redfern, President of Corporate Development, and Victoria ...

GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over ...

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.

Fintel reports that on January 6, 2026, Barclays downgraded their outlook for GSK plc - Depositary Receipt (NYSE:GSK) from ...

Nisha Gopalan is a former Senior Overnight Assignment Editor for Investopedia News. She is an award-winning financial journalist who has worked in London, where she is currently based, and Hong Kong.